Dopamine agents for hepatic encephalopathy

Anders Ellekær Junker; Bodil Als-Nielsen; Christian Gluud; Lise Lotte Gluud

doi:10.1002/14651858.CD003047.pub3

Dopamine agents for hepatic encephalopathy

Anders Ellekær Junker, Bodil Als-Nielsen, Christian Gluud, Lise Lotte Gluud

12 Citationer (Scopus)

Abstract

Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Vol/bind	2
Sider (fra-til)	CD003047
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD003047.pub3
Status	Udgivet - 10 feb. 2014

Adgang til dokumentet

10.1002/14651858.CD003047.pub3

Citationsformater

@article{409ec1e6362e4d818b9a4f96232c14eb,

title = "Dopamine agents for hepatic encephalopathy",

abstract = "Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.",

author = "Junker, {Anders Ellek{\ae}r} and Bodil Als-Nielsen and Christian Gluud and Gluud, {Lise Lotte}",

year = "2014",

month = feb,

day = "10",

doi = "10.1002/14651858.CD003047.pub3",

language = "English",

volume = "2",

pages = "CD003047",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Update Software Ltd",

}

TY - JOUR

T1 - Dopamine agents for hepatic encephalopathy

AU - Junker, Anders Ellekær

AU - Als-Nielsen, Bodil

AU - Gluud, Christian

AU - Gluud, Lise Lotte

PY - 2014/2/10

Y1 - 2014/2/10

N2 - Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

AB - Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patients with Parkinson's disease) have therefore been assessed as a potential treatment for patients with hepatic encephalopathy.

U2 - 10.1002/14651858.CD003047.pub3

DO - 10.1002/14651858.CD003047.pub3

M3 - Journal article

C2 - 24515383

SN - 1469-493X

VL - 2

SP - CD003047

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Dopamine agents for hepatic encephalopathy

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater